title: Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.
abstract: Gram-positive bacteria, such as Staphylococcus aureus, cause serious human illnesses through combinations of surface virulence factors and secretion of exotoxins. Our prior studies using the protein synthesis inhibitor clindamycin and signal transduction inhibitors glycerol monolaurate and α-globin and β-globin chains of hemoglobin indicate that their abilities to inhibit exotoxin production by S. aureus are separable from abilities to inhibit growth of the organism. Additionally, our previous studies suggest that inhibition of exotoxin production, in absence of ability to kill S. aureus and normal flora lactobacilli, will prevent colonization by pathogenic S. aureus, while not interfering with lactobacilli colonization. These disparate activities may be important in development of novel anti-infective agents that do not alter normal flora. We initiated studies to explore the exotoxin-synthesis-inhibition activity of hemoglobin peptides further to develop potential agents to prevent S. aureus infections. We tested synthesized α-globin chain peptides, synthetic variants of α-globin chain peptides, and two human defensins for ability to inhibit exotoxin production without significantly inhibiting S. aureus growth. All of these peptides were weakly or not inhibitory to bacterial growth. However, the peptides were inhibitory to exotoxin production with increasing activity dependent on increasing numbers of positively-charged amino acids. Additionally, the peptides could be immobilized on agarose beads or have amino acid sequences scrambled and still retain exotoxin-synthesis-inhibition. The peptides are not toxic to human vaginal epithelial cells and do not inhibit growth of normal flora L. crispatus. These peptides may interfere with plasma membrane signal transduction in S. aureus due to their positive charges.
authors.affiliation: Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America.
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Merriman
authors.affiliation: The Procter & Gamble Company, Cincinnati, Ohio, United States of America.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Nemeth
authors.affiliation: Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Schlievert
mesh_terms: D000596:Amino Acids / Q000737:chemistry; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D001427:Bacterial Toxins / Q000096:biosynthesis; D004768:Enterotoxins / Q000096:biosynthesis; D004847:Epithelial Cells / Q000378:metabolism / Q000382:microbiology; D005098:Exotoxins / Q000096:biosynthesis*; D005260:Female; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis; D010455:Peptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism; D018089:Superantigens / Q000096:biosynthesis; D023084:alpha-Defensins / Q000494:pharmacology; D055542:alpha-Globins / Q000737:chemistry
chemical_list: D000596:Amino Acids; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D001427:Bacterial Toxins; D004768:Enterotoxins; D005098:Exotoxins; D016209:Interleukin-8; D010455:Peptides; D018089:Superantigens; D023084:alpha-Defensins; D055542:alpha-Globins; C030107:enterotoxin F, Staphylococcal; C406413:human neutrophil peptide 1; C406416:human neutrophil peptide 2
references.citation: Lancet. 1981 May 9;1(8228):1017-21
references.pmid: 6112412
references.citation: Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3360-5
references.pmid: 21282650
references.citation: Science. 1990 May 11;248(4956):705-11
references.pmid: 2185544
references.citation: Microbiology (Reading). 2006 Apr;152(Pt 4):1155-1167
references.pmid: 16549678
references.citation: N Engl J Med. 1980 Dec 18;303(25):1429-35
references.pmid: 7432401
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
references.pmid: 20534435
references.citation: Clin Infect Dis. 2009 Dec 1;49(11):1711-7
references.pmid: 19863450
references.citation: Antimicrob Agents Chemother. 1992 Mar;36(3):626-31
references.pmid: 1622174
references.citation: Antimicrob Agents Chemother. 2013 Aug;57(8):3645-52
references.pmid: 23689713
references.citation: Antimicrob Agents Chemother. 2008 Dec;52(12):4448-54
references.pmid: 18838587
references.citation: Ann Intern Med. 1982 Jun;96(6 Pt 2):937-40
references.pmid: 7091971
references.citation: J Immunol. 1994 Jan 1;152(1):87-95
references.pmid: 8254210
references.citation: J Clin Microbiol. 2000 May;38(5):1797-803
references.pmid: 10790102
references.citation: Am J Obstet Gynecol. 2003 Dec;189(6):1785-91
references.pmid: 14710116
references.citation: Antimicrob Agents Chemother. 2010 Feb;54(2):597-601
references.pmid: 20008774
references.citation: Antimicrob Agents Chemother. 2013 Nov;57(11):5432-7
references.pmid: 23959313
references.citation: Antimicrob Agents Chemother. 2004 Aug;48(8):3057-63
references.pmid: 15273121
references.citation: Biochemistry. 2008 Dec 9;47(49):12995-3003
references.pmid: 19012411
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3056-62
references.pmid: 17576832
references.citation: Biochemistry. 2007 Dec 18;46(50):14349-58
references.pmid: 18020451
references.citation: Curr Microbiol. 2012 Dec;65(6):726-32
references.pmid: 22965624
references.citation: Infect Immun. 2005 Apr;73(4):2164-74
references.pmid: 15784559
references.citation: Peptides. 2004 Nov;25(11):1839-47
references.pmid: 15501514
references.citation: J Clin Microbiol. 2004 Jun;42(6):2875-6
references.pmid: 15184497
references.citation: Annu Rev Microbiol. 2001;55:77-104
references.pmid: 11544350
references.citation: Lancet. 1986 May 17;1(8490):1149-50
references.pmid: 2871397
references.citation: J Pathol. 2006 Jan;208(2):249-60
references.pmid: 16362993
references.citation: J Infect Dis. 2010 Dec 1;202(11):1690-7
references.pmid: 20979456
references.citation: Nat Med. 2007 Dec;13(12):1405-6
references.pmid: 18064027
references.citation: J Infect Dis. 1983 Feb;147(2):236-42
references.pmid: 6827140
references.citation: N Engl J Med. 1998 Aug 20;339(8):520-32
references.pmid: 9709046
references.citation: Clin Microbiol Rev. 2013 Jul;26(3):422-47
references.pmid: 23824366
references.citation: Biochemistry. 2011 Aug 23;50(33):7157-67
references.pmid: 21749039
references.citation: J Clin Immunol. 2007 May;27(3):327-38
references.pmid: 17340193
references.citation: J Infect Dis. 1984 Mar;149(3):471
references.pmid: 6715902
references.citation: J Infect Dis. 2014 Jun 15;209(12):1955-62
references.pmid: 24357631
references.citation: FEBS J. 2011 Dec;278(23):4649-67
references.pmid: 21535475
references.citation: Appl Environ Microbiol. 2003 Feb;69(2):1305-7
references.pmid: 12571063
references.citation: Antonie Van Leeuwenhoek. 2000 Apr;77(3):197-207
references.pmid: 15188884
references.citation: J Infect Dis. 1981 Apr;143(4):509-16
references.pmid: 6972418
references.citation: N Engl J Med. 1980 Dec 18;303(25):1436-42
references.pmid: 7432402
references.citation: Mar Drugs. 2011 Dec;9(12):2537-52
references.pmid: 22363239
references.citation: J Clin Microbiol. 2005 Sep;43(9):4628-34
references.pmid: 16145118
references.citation: J Immunol. 2009 Feb 15;182(4):2364-73
references.pmid: 19201891
references.citation: J Bacteriol. 1994 Jul;176(14):4204-9
references.pmid: 8021206